Search Results 1681-1690 of 24177 for autoimmune hepatitis

  1. Indapamide (oral route) - Side effects & dosage - Mayo Clinic

    Liver disease or; Myopia (nearsightedness) or; Systemic lupus erythematosus (SLE)—Use with caution. May make these conditions worse. Kidney disease—Use with ...

  2. Zanubrutinib (oral route) - Side effects & dosage - Mayo Clinic

    Liver disease—Use with caution. May make these conditions worse. Infection (eg, hepatitis B, herpes simplex, pneumonia)—May decrease your body's ability to ...

  3. Hepatocellular carcinoma (HCC) - Survival rates - Mayo Clinic

    In this situation, the five-year survival rate can be as high as 90%. For those who also have liver disease, liver transplant also can cure the cancer. Studies ...

  4. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have pinpointed how excessive alcohol consumption contributes to fatty liver disease. Latest stories. New Mayo Clinic study advances ...

  5. Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes (REGENT-1-US) - Mayo Clinic

    Known autoimmune disease, as evidenced by a positive anti-glutamic acid ... Known active hepatitis or active liver disease other than NASH/NAFLD.

  6. Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer - Mayo Clinic

    No active autoimmune disease or history of autoimmune ... hepatitis; and patients with a history of toxic ... No known active Hepatitis B (e.g., HBsAg reactive) or ...

  7. TN-401, A Recombinant Adeno-associated Virus Serotype 9 (AAV9) Containing Plakophilin-2 (PKP2) Transgene, In Adults With PKP2 Mutation-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) - Mayo Clinic

    ... autoimmune disorder (e.g., systemic lupus ... History of hepatitis C virus (HCV), hepatitis B ... History of clinically significant liver disease, liver transplant, ...

  8. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    alcoholic, or other hepatitis; cirrhosis; fatty liver; and inherited liver disease. - Patients with past or resolved hepatitis B infection (defined as having a

  9. Study of TERN-601 in Adults with Overweight or Obesity - Mayo Clinic

    Evidence of hepatitis B and/or positive hepatitis B surface antigen. ... Participants treated for hepatitis ... autoimmune or congenital anemia (eg, hemolytic ...

  10. Pirtobrutinib And Venetoclax With MRD Detection For Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    * Autoimmune complications including anemia or thrombocytopenia poorly responsive to corticosteroids. ... * Active uncontrolled autoimmune complications (e.g., ...